Greenland Mines Ltd

Greenland Mines Ltd operates in the cell and gene therapy and natural resources businesses. It explores palladium, gold, and platinum deposits, focusing on the Skaergaard project in Southeast Greenland and the Sarartoq neodymium-praseodymium (Nd-Pr) rare earths project in Southwest Greenland. The company is also developing KLTO-202, a gene therapy for the treatment and prevention of amyotrophic lateral sclerosis, and KLTO-101 for the treatment or prevention of Alzheimer's disease, as well as therapies for Parkinson's and other age-related disorders. Formerly known as Klotho Neurosciences, Inc., it changed its name to Greenland Mines Ltd in March 2026 and is based in Charlotte, North Carolina.